Evommune (EVMN) Stock Price
Evommune Price
Revenue has compounded at 61.2% per year over the past 2 years to 13.00 M USD. Evommune's net margin stands at -529.8%, up from -681.1% several years earlier.
Evommune stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Evommune business model & stock analysis
Frequently asked questions about Evommune
19 analysts currently rate the Evommune stock: 15 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Evommune to generate revenue of 714,290.00 USD and earnings per share of -3.22 USD.
Converted at the current exchange rate, the Evommune share trades at 6.01 EUR (6.73 USD).
The expected revenue of Evommune is 714,290.00 USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Evommune is -101.63 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Evommune is currently -2.09. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Evommune stock.
The price-to-sales ratio (P/S) of Evommune is currently 297.02. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Evommune stock.
The Eulerpool Quality Score for Evommune is 2/10.
The ISIN of Evommune is US30054Y1073. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Evommune is EVMN. The ticker symbol is used to trade Evommune shares on the stock exchange.
Evommune stock
Evommune Peer Group
All fundamentals and in-depth analysis of Evommune
Our stock analysis for Evommune stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evommune. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.